Pre- and post-HSCT CD4+CD25bright cells in peripheral blood
| Group . | No. of patients . | Percentage CD4+CD25bright, mean ± SD . | Absolute CD4+CD25bright, mean cells/μL . | P (compared with pre-HSCT) . |
|---|---|---|---|---|
| Normal control | 8 | 3.86 ± 1.67 | NA | NA |
| pre-HSCT | 13 | 2.62 ± 2.01 | 22 | NA |
| 6 months post-HSCT | 9 | 2.91 ± 1.74 | 24 | < .05 |
| 1 year post-HSCT | 13 | 3.55 ± 1.63 | 54 | < .05 |
| 2 years post-HSCT | 10 | 3.36 ± 1.63 | 48 | < .05 |
| 3 year, post-HSCT | 4 | 3.99 ± 0.78 | 62 | NS |
| Group . | No. of patients . | Percentage CD4+CD25bright, mean ± SD . | Absolute CD4+CD25bright, mean cells/μL . | P (compared with pre-HSCT) . |
|---|---|---|---|---|
| Normal control | 8 | 3.86 ± 1.67 | NA | NA |
| pre-HSCT | 13 | 2.62 ± 2.01 | 22 | NA |
| 6 months post-HSCT | 9 | 2.91 ± 1.74 | 24 | < .05 |
| 1 year post-HSCT | 13 | 3.55 ± 1.63 | 54 | < .05 |
| 2 years post-HSCT | 10 | 3.36 ± 1.63 | 48 | < .05 |
| 3 year, post-HSCT | 4 | 3.99 ± 0.78 | 62 | NS |
CD indicates cluster differentiation antigen; NA, not available; and NS, not significant.